Development of innovative antimicrobials against pathogens resistant to antimicrobials

Grantavia

P

Funding Match^Beta

We use essential, analytics, and advertising cookies to improve the experience, measure usage, and optimize campaigns.

Essential

Required for the site to function and cannot be disabled.

Analytics

Help us understand usage to improve the service.

Advertising

Allow us to measure campaigns and optimize advertising related to our services.

Learn more at Privacy Policy · Terms of Service · Cookie Policy

Description

Europe

Health & Life Sciences•100% • 44.2M€

Pending

Dates & Deadlines

Publication Date

October 16, 2026

Opening Date

October 29, 2026

Application Phases

Fase única

February 17, 2027 at 05:00 PM

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

44.2M€

Eligible Project Value

8M€ - 10M€

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget

Result Indicators

●Reduction in disease burden (DALYs reduction)
●Reduction in premature mortality from non-communicable diseases
●Improved research and innovation capacity for health threats
●Cross-border health threat mitigation

EU Programme Details

Call ID: HORIZON-HLTH-2027-01-DISEASE-08
Cluster: Health
Destination: D3. Tackling diseases and reducing disease burden
Submission Mode: Single-stage
EU Contribution: Around €8,000,000.00 to €10,000,000.00 per project
Expected Projects: 5 projects
Funding Rate Rule: Up to 100% of eligible costs for Research and Innovation Actions (RIA)

Funding Rate

100%

Budget

44.2M€

Curated by

Marlene Faria

Eligibility

Eligible Sectors

Health & Life Sciences

Company Typologies

MicroSMELargePrivate non-profit entitiesPublic entities

Application Mode

Consortium / Copromotion

Action Types

Research and Innovation ActionInternational cooperationDisease managementPandemic preparednessAntimicrobial resistance solutionsDigital health solutionsMental health initiativesRare disease support

Official Links

Official Regulation

Cookies